Income Protection or PHI Rider After a Cancer Diagnosis
Priya, 41, is a self-employed graphic designer earning €68,000. Two years ago she completed treatment for Stage II breast cancer and is now in remission, under annual oncology review with no recurrence. She holds an older private medical insurance (PMI) policy with a €500 excess that excludes pre-existing conditions for two years from inception, and it is now past that exclusion window. Her broker suggests she add a hospital cash / income protection rider to the PMI. Priya's main concern is that if she is unable to work for several months, her mortgage (€1,450/month) and living costs continue. She has €9,000 in savings and no other income protection. She asks whether the rider is the right tool and whether her cancer history will be an issue.
1. Advise Priya on whether a PMI hospital-cash rider is an adequate substitute for income protection, explaining the different risks each product addresses.
Read the worked answer
They cover different risks and should not be treated as substitutes.
- PMI / hospital cash reimburses or pays a fixed daily amount for medical treatment - it responds to the cost or occurrence of illness, not to lost earnings. A daily cash benefit is typically modest and time-limited and is not calibrated to her €1,450 mortgage plus living costs.
- Income protection (IP) pays a replacement proportion of earned income (commonly around 50–70%) after a deferred period, for as long as she remains unable to work under the policy definition. That is the product that actually addresses the mortgage-continuity risk she describes.
With only €9,000 savings (roughly six months of mortgage alone, before living costs), her real exposure is a prolonged inability to earn. The rider leaves that unaddressed. The correct recommendation is a standalone income protection policy (or at minimum a serious-illness/PHI structure explicitly designed for income replacement), with the PMI retained for treatment costs.
2. Priya's cancer history is disclosed. Explain how underwriting is likely to treat it and what practical steps improve her chances of cover.
Read the worked answer
A prior cancer is a material fact and must be disclosed fully and accurately; non-disclosure would risk a claim being declined or the policy avoided.
Underwriting will focus on: type and stage, date of diagnosis, treatment completed, date of last treatment, current remission status, surveillance schedule and any recurrence. Insurers commonly postpone or decline within a defined period after treatment and may offer cover with a loading or an exclusion (e.g. excluding claims arising from the treated condition) once a remission period has passed.
Practical steps:
- Provide the full oncology history and latest review letter up front rather than drip-feeding information.
- Approach several insurers, including those known to consider post-cancer applications, and consider a specialist broker.
- Expect the income protection element to be the hardest to place; even if a cancer-related exclusion applies, cover for other causes of incapacity still has real value.
- Revisit the market periodically - terms often improve with longer remission.
She should not rely on the existing PMI's expired pre-existing exclusion as evidence she is now insurable for income protection; the two underwriting assessments are separate.